Payment overview · 2025
General Payments
$18.94
1 reported records · 1 companies
Healthcare provider profile · identity verified
Eric Doerfler, MD
Allopathic & Osteopathic Physicians|Family Medicine · BATTLE GROUND, WA · NPI 1558318626
Verified facts
What the public records show
CMS Open Payments records show Eric Doerfler, MD received $18.94 in general payments during 2025 across 1 reported records.
Phathom Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $18.94 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.94 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $18.94 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 652 | 171 |
| Amlodipine Besylate | Amlodipine Besylate | 588 | 150 |
| Losartan Potassium | Losartan Potassium | 438 | 120 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 356 | 73 |
| Levothyroxine Sodium | Levothyroxine Sodium | 332 | 86 |
| Lisinopril | Lisinopril | 294 | 85 |
| Tamsulosin Hcl | Tamsulosin Hcl | 284 | 73 |
| Pantoprazole Sodium | Pantoprazole Sodium | 237 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 215 | 66 |
| Omeprazole | Omeprazole | 201 | 58 |
| Metoprolol Succinate | Metoprolol Succinate | 165 | 51 |
| Metformin Hcl | Metformin Hcl | 162 | 43 |
| Allopurinol | Allopurinol | 157 | 38 |
| Eliquis | Apixaban | 152 | 29 |
| Trazodone Hcl | Trazodone Hcl | 152 | 38 |
| Pregabalin | Pregabalin | 148 | 26 |
| Meloxicam | Meloxicam | 133 | 41 |
| Oxycodone Hcl | Oxycodone Hcl | 131 | 31 |
| Gabapentin | Gabapentin | 130 | 41 |
| Simvastatin | Simvastatin | 127 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 126 | 35 |
| Furosemide | Furosemide | 125 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 118 | 30 |
| Zolpidem Tartrate | Zolpidem Tartrate | 118 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 114 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 112 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 109 | 31 |
| Metformin Hcl Er | Metformin Hcl | 105 | 30 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 105 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 102 | 48 |
| Ozempic | Semaglutide | 92 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 88 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 87 | 53 |
| Lovastatin | Lovastatin | 86 | 23 |
| Sertraline Hcl | Sertraline Hcl | 80 | 25 |
| Alprazolam | Alprazolam | 77 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 77 | 21 |
| Lorazepam | Lorazepam | 73 | 24 |
| Atenolol | Atenolol | 69 | 15 |
| Methocarbamol | Methocarbamol | 68 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 67 | 15 |
| Spironolactone | Spironolactone | 67 | 21 |
| Tramadol Hcl | Tramadol Hcl | 66 | 16 |
| Potassium Chloride | Potassium Chloride | 65 | 17 |
| Carvedilol | Carvedilol | 64 | 19 |
| Finasteride | Finasteride | 63 | 14 |
| Azithromycin | Azithromycin | 59 | 38 |
| Alendronate Sodium | Alendronate Sodium | 56 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 21 |
| Celecoxib | Celecoxib | 55 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 55 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 14 |
| Ondansetron Odt | Ondansetron | 52 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 50 | 14 |
| Prednisone | Prednisone | 49 | 31 |
| Famotidine | Famotidine | 44 | suppressed |
| Diazepam | Diazepam | 43 | suppressed |
| Clonazepam | Clonazepam | 42 | suppressed |
| Ketoconazole | Ketoconazole | 42 | 26 |
| Donepezil Hcl | Donepezil Hcl | 40 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 40 | suppressed |
| Mounjaro | Tirzepatide | 40 | suppressed |
| Nitroglycerin | Nitroglycerin | 40 | 26 |
| Fluticasone Propionate | Fluticasone Propionate | 38 | 17 |
| Glimepiride | Glimepiride | 38 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 37 | 16 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 36 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 36 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 34 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 33 | suppressed |
| Baclofen | Baclofen | 32 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | suppressed |
| Estradiol | Estradiol | 31 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 31 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 29 | 15 |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Jardiance | Empagliflozin | 28 | suppressed |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 28 | suppressed |
| Acyclovir | Acyclovir | 26 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 21 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 19 |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Eszopiclone | Eszopiclone | 23 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 15 |
| Sucralfate | Sucralfate | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Testosterone | Testosterone | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Procto-Med Hc | Hydrocortisone | 19 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Memantine Hcl | Memantine Hcl | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Xtampza Er | Oxycodone Myristate | 18 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Xarelto | Rivaroxaban | 17 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Synthroid | Levothyroxine Sodium | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Oxycontin | Oxycodone Hcl | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Cefdinir | Cefdinir | 13 | 11 |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Lamotrigine Er | Lamotrigine | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Mitigare | Colchicine | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Xultophy 100-3.6 | Insulin Degludec/Liraglutide | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Ezetimibe | Ezetimibe | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.94 · 1 records | Phathom Pharmaceuticals, Inc. | VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error